Seaya reaches €600M first close for Seaya Nova; Ambrose buys AM-Pharma

The story so far, in brief; the legwork, and the full article, stay with the original outlet.

Seaya has made a first close of €600M for its new fund, Seaya Nova. Ambrose Healthcare is buying AM-Pharma, a company backed by Ysios, for up to €161M. Advent, meanwhile, raised $30,000M for its global fund platform, a figure that makes much of what follows look like rounding.

Swanlaab put €1M into RawData, Mouro led a $15M Series A in Overwatch Data, and the EIB provided €40M of financing to Impress for its clinical AI platform. OmniWallet raised €220,000 after five years of technology development.

The appetite for running funds continues: Masia closed its first fund at €18M, Talde launched one of up to €125M for robotics and aerospace, Santander put €4,400M into its venture capital unit, and the owners of turrón maker Delaviuda are moving into venture capital too.